Monday, March 25th | 18 Adar II 5779

Subscribe
December 9, 2018 11:53 am

Richard Gere to Star in Apple Adaptation of Israeli Series ‘Nevelot’

avatar by Shiryn Ghermezian

Email a copy of "Richard Gere to Star in Apple Adaptation of Israeli Series ‘Nevelot’" to a friend

Richard Gere. Photo: Wikimedia Commons.

Apple is negotiating for the rights to adapt an Israeli television series that will star Richard Gere, Variety reported on Thursday.

The drama “Nevelot” revolves around two elderly Vietnam veterans and best friends whose lives are changed when a woman they both loved 50 years ago is killed in a car accident. The military veterans seek revenge and “go on a youth-focused killing spree because they believe today’s kids don’t understand the sacrifices of their generation,” according to CNBC.

If “Nevelot” goes to series it would be for an eight-episode first season. It is based on a novel of the same name by Israeli author Yoram Kaniuk. The original show, which had only five episodes, aired on Israel’s HOT network in 2010 and won the prize for best miniseries at the Israeli Television Academy Awards.

Apple and 21st Century Fox will be co-producing the show, which was previously in development at HBO but the network eventually dropped the project. The show will be written by Howard Gordon, who developed “Homeland” for Showtime, and Warren Leight, who helped adapt the Israeli show “In Treatment” for HBO.

“There’s nothing more joyful or more reassuring then to hand off our baby, ‘Nevelot,’ to producers of this quality, who will undoubtedly bring it to excellent places,” said Dror Sabo, co-creator of the original HOT show and producer of the American remake. “We met Howard Gordon at the Fox Studios in Los Angeles. To see the strong effect the Hebrew series had on them, to hear their praise and their astonishment when they understand the conditions and limitations we operate under, warms the heart and spurs us to do more. It’s going to be exciting and interesting.”

Share this Story: Share On Facebook Share On Twitter Email This Article

Let your voice be heard!

Join the Algemeiner

Algemeiner.com